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Background: Prevention of nosocomial transmission of infections is a central responsibility in the healthcare
environment, and accurate identification of transmission events presents the first challenge. Phylogenetic
analysis based on whole genome sequencing provides a high-resolution approach for accurately relating
isolates to one another, allowing precise identification or exclusion of transmission events and sources for
nearly all cases. We sequenced 24 methicillin-resistant Staphylococcus aureus (MRSA) genomes to retrospectively
investigate a suspected point source of three surgical site infections (SSIs) that occurred over a one-year period.
The source of transmission was believed to be a surgical team member colonized with MRSA, involved in all
surgeries preceding the SSI cases, who was subsequently decolonized. Genetic relatedness among isolates was
determined using whole genome single nucleotide polymorphism (SNP) data.
Results: Whole genome SNP typing (WGST) revealed 283 informative SNPs between the surgical team member’s
isolate and the closest SSI isolate. The second isolate was 286 and the third was thousands of SNPs different, indicating
the nasal carriage strain from the surgical team member was not the source of the SSIs. Given the mutation rates
estimated for S. aureus, none of the SSI isolates share a common ancestor within the past 16 years, further discounting
any common point source for these infections. The decolonization procedures and resources spent on the point
source infection control could have been prevented if WGST was performed at the time of the suspected transmission,
instead of retrospectively.
Conclusions: Whole genome sequence analysis is an ideal method to exclude isolates involved in transmission events
and nosocomial outbreaks, and coupling this method with epidemiological data can determine if a transmission event
occurred. These methods promise to direct infection control resources more appropriately.
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Table 1 Clinical histories of patients with MRSA infections,
including suspected index case
Patient Isolates Source Year Collected
Surgical Team
Member
1 Nasal February 2011
Case 2 1 Blood February 2011
Case 3a 3 Abdominal fluid September 2010
Case 3b - Anal fistula August 2011
Case 3c - Sputum August 2011
Case 4 1 Deep wound July 2010
Hospital Control 1 1 Tissue March 2010
Hospital Control 2 1 Incision December 2010
Hospital Control 3 1 Joint fluid September 2010
Hospital Control 4a 2 Tissue March 2010
Hospital Control 4b - Deep wound March 2010
Hospital Control 5 1 Tissue November 2010
Hospital Control 6 1 Tissue October 2010
Hospital Control 7 1 Deep wound December 2010
Hospital Control 8a 2 Abdominal fluid February 2011
Hospital Control 8b - Abdominal fluid February 2011
Healthcare Control 9a 2 Head February 2011
Healthcare Control 9b - Head February 2011
Healthcare Control 10 1 Right stump March 2011
Healthcare Control 11 1 Urine February 2011
Community Control 12 1 Blood March 2011
Community Control 13 1 Boil October 2010
Community Control 14 1 Abscess groin February 2011
Community Control 15 1 Excision site
abdominal
March 2011
Multiple samples taken from individuals are labeled as “a”, “b”, and “c”
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Surgical site infections (SSIs) account for 31 % of all
healthcare-associated infections in the United States [1].
A critical risk factor for the development of a SSI is the
severity of wound contamination during surgery [2, 3].
As one of the most predominant organisms colonizing
the skin, Staphylococcus aureus is a common causative
agent of SSI [4], and methicillin-resistant S. aureus
(MRSA) accounts for 15 % of reported SSIs [5]. The
most significantly associated independent circumstance
for the development of a S. aureus SSI is nasal carriage
by the patient [3]. Studies that examined perioperative
decolonization of patients using intranasal mupirocin
showed a significant decrease in the risk of developing a
SSI [6–8]. The risk of a S. aureus SSI associated with
S. aureus nasal carriage or colonization of surgical
team members is unknown.
The implementation of whole genome sequencing
(WGS) in the clinical setting to closely analyze isolates
has allowed for precise identification and characterization
of putative transmission events among patients. WGS also
allows for high resolution analysis of source tracing in
hospitals which can have the potential to impact hospital-
based outbreak investigations and infection prevention
practices [9–12]. To our knowledge, however, no study
has investigated MRSA carriage among surgical staff
members as a source of MRSA transmission to surgical
patients using WGST.
In this study, a hospital infection control team identi-
fied a cluster of MRSA SSIs from a single surgical team.
Antibiotic susceptibility profiles suggested that the cases
were related. The surgical team in question was screened
for nasal carriage by the infection control team and one
member tested positive for MRSA by PCR, as well as
by culture. The surgical team member was decolonized
per hospital protocol, and the MRSA decolonization was
documented as successful, based on further nasal screen-
ing. In this study, we retrospectively examine the MRSA
strain from the colonized surgical team member along
with patient and control strains to determine whether
it was the source of the cluster of SSIs using whole
genome single nucleotide polymorphism (SNP) typing
(WGST) [13–15]. These results demonstrate the utility of
WGST for hospital molecular epidemiology and provide
confirmation that the source of infection for three patients
was not related to the surgical team member isolate.
Methods
Surveillance
From February 2010 to August 2011, 24 MRSA isolates
were obtained from 18 patients and one surgical team
member in a rural 280-bed hospital (Table 1). Isolates
were obtained from remaining samples previously col-
lected for in-house testing as approved by the InstitutionalReview Board of the participating institution. No patient
consent was needed as samples obtained were isolates
only. The isolates fell into three groups; the first group
comprised the surgical team member’s isolate (suspected
point source) and three patients’ SSI isolates. The three
isolates were from patients who developed MRSA surgical
site infections following surgical procedures by the same
medical team. The surgical team in question was screened
for nasal carriage and one member tested positive for
MRSA by the GeneXpert Infinity MRSA PCR (Cepheid),
and subsequently MRSA was cultured from the original
swab providing the surgical team member isolate. The
surgical team member’s isolate was tested and confirmed
positive for mecA, an assay included in the GeneXpert
PCR assay.
The second group consisted of 10 background isolates
considered to have no association with the first group of
samples but were also from SSIs, collected randomly
from the regular sample flow at the hospital. The third
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collected, from outpatients and patients admitted to
the hospital with MRSA infections. These isolates were
sourced from blood, sputum, wound and urine specimens.
In all three groups of isolates, multiple samples from indi-
vidual patients, labeled as “a” and “b”, were taken over
time to serve as a control threshold for genetic similarity
and relatedness.
DNA sequencing
Isolates were grown on trypticase soy agar media and
DNA was prepared using DNeasy Blood & Tissue Kit
as described by the manufacturer (Qiagen, Valencia,
CA) with the addition of lysostaphin to the gram-
positive extraction protocol from Qiagen. The DNA
samples were prepared for multiplexed, paired-end
sequencing with a 500 base pair insert using Library
Preparation Kit with Standard PCR Library Amplifica-
tion (KAPA Biosystems, Woburn, MA). A 100 bp
read paired-end run was used for all twenty-four iso-
lates on the GAIIx sequencing platform (Illumina,
Inc. San Diego, CA).
SNP phylogenetic analysis
A phylogeny of all the MRSA isolates was constructed
based on a matrix that tabulates all SNPs among the
genomes of the isolates by their locus within a reference
genome. The matrix was generated using the Northern
Arizona SNP Pipeline (NASP) [16]. NASP aligns DNA
sequencing reads to a reference, identifies SNPs and
filters SNP loci based on user-defined parameters as
previously described [14, 15, 17–19]. NASP generated a
matrix for this study by aligning sequence reads from
the 24 isolates to the reference genome, FPR3757
(NCBI accession number: NC_007793), using Novoalign
(Novocraft.com). Reads that mapped to multiple locations
within the reference genome were excluded from the
alignments as were reads containing insertions or dele-
tions. SNPs were identified in the alignments using the
Genome Analysis Toolkit (GATK) [20]. Only SNP loci
found throughout all samples were used for the phylogen-
etic analysis. Additionally, SNPs had to be in >90 % of
the reads and have minimum 10× coverage to be included
in a final matrix. MUMmer version 3.22 [21] was used
to identify duplicated regions within FPR3757 and SNP
loci within these regions were removed from the final
analysis. The phylogenetic analysis of the high-quality
core genome SNP matrix was performed with MEGA
version 5.05 [22] using the maximum parsimony algo-
rithm and bootstrap analysis with 1,000 replicates. Read
depth statistics and reference coverage were determined
from NASP. The whole genome sequence read files were
deposited in the NCBI Sequence Read Archive under
BioProject ID PRJNA255788. Read data were also used toidentify the multi-locus sequence type (MLST) as well




The sequence analysis provided appropriate depth and
breadth of sequence coverage across all isolates to con-
duct robust WGST analysis. Mean quality breadth of the
reference genome FPR3757 for all samples was ≥91.36 %
with a mean read-depth of 103X (Additional file 1: Table
S1). The phylogeny constructed was based on 18,520
parsimony informative SNPs and revealed two distinct
clades (Fig. 1). MLST analysis using WGS data identified
these clades as two distinct clonal complexes: CC5,
which is known to include a major clone historically
associated with healthcare-associated infections; and CC8,
a major clonal group of largely community-acquired
strains. CC5 and CC8 represent two distantly related
lineages of S. aureus that are common in hospitals
across the country [24, 25].
WGST analysis demonstrated that no obvious trans-
mission event occurred between the colonized surgi-
cal team member and patients. First, the two distinct
clades in the phylogenetic tree, CC5 and CC8, are
separated by 17,042 SNPs. The surgical team member
isolate and one of the MRSA SSI cluster isolates,
Case 3, are located in CC5 and CC8 respectively. Sec-
ond, the surgical team member isolate is 283 SNPs
different from the closest case isolate, Case 2, and
even more distant from the third, Case 4. Estimates
of the mutation rate for S. aureus have been calcu-
lated repeatedly at a rate of approximately 3.3 × 10−6
mutations per site per year, or one core genome SNP
every 6 to 7 weeks [26–28]. Using this estimate, there
should be approximately 7 to 8 SNPs per year after
strains diverge from a common ancestor due to base-
line mutation alone. Given their 283 SNP separation,
the isolates from the surgical team member and Case
2 had a common ancestor more than 16 years prior
to the surgery. Case 4, the other suspected related
isolate, was as distant from the surgical team member
isolate as Case 2, with a 285 SNP differentiation.
Additionally, in order to determine epidemiologically
related and unrelated isolates using WGST, a threshold
was established from a set of related isolates for our
study, using multiple samples taken from individual pa-
tients over time (Healthcare Control 9a and 9b, Case 3,
3a and 3b, Hospital Control 8a and 8b and Hospital
Control 4a and 4b). The average pairwise distance be-
tween each set of related isolates was 2.3 SNPs with the
exception of Case 3. Case 3, 3a and 3b were from the
same patient over the span of one year and taken from
multiple body sites. These three isolates contained 21
Fig. 1 Phylogenetic SNP analysis. Unrooted phylogenetic SNP analysis based on whole genome sequence data of 24 MRSA isolates using
the maximum parsimony algorithm
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any two isolates; however, this number is still within the
predicted baseline mutation rate of S. aureus. Healthcare
control samples 9a, 9b and 11, collected from two diffe-
rent patients, had two SNP differences separating them,
indicating a likely recent transmission event, probably
within the long-term care facility where both patients
resided.
Discussion
Our investigation indicates that the surgical team mem-
ber isolate was not the source of a transmission event
and that no evidence of transmission occurred among
the suspect cases. It is well established that humans are
commonly colonized with S. aureus, with a fraction of
the population being carriers of MRSA; a recent review,
published in 2014, investigating MRSA carriage among
healthcare workers in non-outbreak settings in Europe
and the United States estimated between under 1 % and
15 % of hospital staff are MRSA carriers [29]. A recent
study from the Netherlands, published in 2015, estimates
S. aureus carriage among surgeons as high as 45.4 %
[30]. A high incidence of both methicillin-susceptibleS. aureus (MSSA) andMRSA nasal carriage are exacerbating
the increasing number of healthcare-associated S. aureus
infections in patient care facilities [31]. Reducing pa-
tient colonization has been hypothesized to help in the
prevention of MRSA transmission and infection [32, 33].
However, the impact of MRSA carriage by medical pro-
viders and hospital ancillary staff when compared to the
MRSA nasal carriage rate of patients, in association with
the incidence of MRSA nosocomial infections, is still not
well understood but has been speculated as a source of
patient infection [30, 34, 35]. Such provider to patient
transmission would have significant liability, reimbur-
sement and risk management implications for both pro-
viders and healthcare facilities. In this study, we used
high-resolution techniques to compare a MRSA isolate
carried by a surgical team member to the MRSA isolates
of that surgical team member’s patients who had post-
operative SSIs. WGST confirmed that transmission events
did not occur between a healthcare provider and the
surgical patients examined. In order to determine accurate
epidemiological association, background control isolates
from the hospital and community were compared to the
suspected cluster isolates. By including these background
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have observed a clear phylogenetic distinction between
the background isolates and the isolates involved in the
transmission event. However, we identified more than
17,000 parsimony informative SNPs among the 24 isolates
and we did not observe a distinct grouping of the isolates
that were originally thought to be surgery-associated
transmission events. Additionally, an WGS-MLST analysis
confirmed that the surgeon’s isolate was in fact a single
locus variant (ST225) of ST5 and a distinct lineage from
the other isolates (Additional file 2: Table S2). Further-
more, a review of the presence/absence of critical anti-
biotic resistance genes did not reveal any patterns of
interest among the isolates (Additional file 3: Table S3).
WGST has been successfully used as a molecular epi-
demiology tool for numerous outbreak investigations
[13–15, 17–19, 36], replacing older standards such as
PFGE due to increased sensitivity and specificity [37].
Our study further establishes the effectiveness of WGST
for epidemiological investigations within a hospital setting,
which is especially critical for rapid analysis during an
ongoing outbreak. Interestingly, we identified a previously
unrecognized transmission event outside the hospital that
likely would not have been discovered without WGST.
Furthermore, this study highlights the need for additional
investigation to identify the source of hospital-acquired
MRSA infections, including but not limited to medical
providers, hospital staff members and the patient’s own
nasal colonization, as well as the importance of source
tracing to correctly identify an outbreak.
Implementing the reported mutation rate within our
data further weakens our hypothesis of a healthcare
provider-related transmission, with at least 16 years of
evolutionary time between the isolates from the surgical
team member and the respective patients. Furthermore,
the high resolution of WGST provides a genetic thres-
hold to gauge relatedness between isolates collected
from a single patient from multiple body sites and over
time in comparison to isolates from unrelated patients.
This genetic relatedness framework also allowed for
the detection of a previously unrecognized MRSA trans-
mission event. These data also suggest importation of
strains circulating in other care facilities is a potential
source for hospital-acquired infections.
A limitation of this study is the sequencing of a single
colony from the suspected source. Recent research shows
the bacterial diversity within a host can impede accurate
depiction of transmission events [38]. Pathogen genetic
diversity within a host can be widespread and may be due
to numerous transmissions from multiple sources [38].
Furthermore, S. aureus studies reveal carriage of numer-
ous sequence types within a single host likely due to
multiple independent transmissions [39, 40]. In order to
account for within-host diversity and reduce the risk offalsely interpreting results, it will be important to increase
the sampling of isolates from the suspected source in
future investigations. However, the fact that none of the
three SSI isolates were related to one another provides
evidence against a point source regardless of the single
isolate sampling from the surgical team member.Conclusions
The lack of a MRSA transmission event between the
colonized surgical team member and the surgical patients
shown here has implications in the healthcare field, from
infection prevention to hospital epidemiology and health-
care reimbursement. These findings were only apparent
through the use of WGST. Low resolution strain typing
methods like antibiogram profiles may lead to erroneous
conclusions, and may instigate inappropriate, costly, and
ineffective infection control measures as was the case
here, as well as limit reimbursement for inpatient services
from third-party payers (e.g., CMS) [41]. The accurate
determination or repudiation of a healthcare-associated
outbreak or cluster will prevent unnecessary, disruptive
and costly infection prevention procedures and allow the
implementation of these control measures when they are
appropriate. With the increasing reality of clinical labora-
tory bacterial sequencing and accessible analysis tools,
healthcare and public health systems would do well to
maintain isolate and/or sequence repositories of local
critical nosocomial pathogens to quickly detect and analyze
possible hospital associated infection (HAI) outbreaks.Additional files
Additional file 1: Table S1. Sequencing quality and coverage. Quality
breadth is based on the total reference size, 2,780,693 bases, after
duplicated regions were removed. In order to pass quality filtering,
the loci had to have >10× coverage and a SNP state had to be in
>90 % of the reads to be considered. Mean coverage was calculated
using a genome size of 2.8 Mb. (DOC 54 kb)
Additional file 2: Table S2. Multi-Locus Sequence Type results obtained
from WGS data using SRST2. NF indicates not found and (*) indicates
mismatches. (DOC 52 kb)
Additional file 3: Table S3. Antibiotic resistance gene profiles from
WGS data using SRST2 and the ARGannot database. Genes marked with
(*) indicate non-precise matches and (?) indicates uncertainty due to
coverage. A (− ) indicates the gene was absent. Different antibiotic
classes are abbreviated as AGly: aminoglycosides, Bla: beta-lactamases,
Fos: fosfomycin, Flq: fluoroquinolones, Gly: glycopeptides, MLS:
macrolide-lincosamide-streptogramin, Phe: phenicols, and Tet:
tetracyclines. (XLS 39 kb)Abbreviations
GATK: Genome analysis toolkit; HAI: Hospital associated infection;
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aureus; MSSA: Methicillin resistant Staphylococcus aureus; NASP: Northern
Arizona SNP pipeline; PCR: Polymerase chain reaction; PFGE: Pulse-field gel
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genome SNP typing
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